Two Sigma Investments
BMY icon

Two Sigma Investments’s Bristol-Myers Squibb BMY Stock Holding History

Two Sigma Investments’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.12M Buy
+18,400
New +$1.07M ﹤0.01% 3180
2022
Q1 		– Sell
-212,400
Closed -$13.2M – 2818
2021
Q4 		$13.2M Buy
212,400
+201,100
+1,780% +$11.8M 0.03% 654
2021
Q3 		$669K Sell
11,300
-105,200
-90% -$6.93M ﹤0.01% 3000
2021
Q2 		$7.79M Sell
116,500
-279,000
-71% -$18.2M 0.02% 950
2021
Q1 		$25M Buy
395,500
+370,800
+1,501% +$23.1M 0.07% 356
2020
Q4 		$1.53M Sell
24,700
-131,600
-84% -$8.09M ﹤0.01% 1679
2020
Q3 		$9.42M Buy
156,300
+152,200
+3,712% +$9.16M 0.03% 523
2020
Q2 		$241K Sell
4,100
-302,800
-99% -$18.1M ﹤0.01% 2517
2020
Q1 		$17.1M Buy
306,900
+192,900
+169% +$11.8M 0.14% 151
2019
Q4 		$7.32M Sell
114,000
-18,500
-14% -$1.06M 0.02% 754
2019
Q3 		$6.72M Buy
132,500
+31,600
+31% +$1.49M 0.02% 721
2019
Q2 		$4.58M Buy
+100,900
New +$4.7M 0.02% 945
2018
Q4 		– Sell
-54,800
Closed -$3.4M – 2998
2018
Q3 		$3.4M Sell
54,800
-67,600
-55% -$4.01M 0.01% 1134
2018
Q2 		$6.77M Buy
122,400
+45,500
+59% +$2.46M 0.02% 875
2018
Q1 		$4.86M Buy
+76,900
New +$4.95M 0.02% 963
2017
Q2 		– Sell
-24,800
Closed -$1.35M – 2963
2017
Q1 		$1.35M Sell
24,800
-42,300
-63% -$2.32M ﹤0.01% 1719
2016
Q4 		$3.92M Buy
67,100
+16,700
+33% +$913K 0.02% 981
2016
Q3 		$2.72M Sell
50,400
-43,600
-46% -$2.8M 0.01% 1248
2016
Q2 		$6.91M Buy
94,000
+18,000
+24% +$1.27M 0.03% 630
2016
Q1 		$4.86M Sell
76,000
-88,000
-54% -$5.55M 0.02% 726
2015
Q4 		$11.3M Buy
+164,000
New +$10.8M 0.05% 380

Other funds holding BMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Two Sigma Investments's BMY Position: Q1 2026 in Review

Two Sigma Investments increased its Bristol-Myers Squibb (BMY) stake by 147% in Q1 2026, buying an estimated $401M and bringing the position to 11,535,106 shares worth $700M. The position accounts for 0.56% of the portfolio, ranked #16.

Two Sigma Investments first reported a position in BMY in Q3 2013 and has held it in 45 quarters since. 2,517 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Two Sigma Investments held 11,535,106 shares of Bristol-Myers Squibb worth $700M as of Q1 2026.
  • Two Sigma Investments bought 6,873,064 Bristol-Myers Squibb shares in Q1 2026, an estimated $401M.
  • Bristol-Myers Squibb made up 0.56% of Two Sigma Investments's portfolio in Q1 2026, its #16 holding.
  • Two Sigma Investments first reported a position in Bristol-Myers Squibb in Q3 2013 and has held it in 45 quarters since.
  • 2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Two Sigma Investments's 13F filing for Q1 2026, filed 15 May 2026.